Hamidreza Jamaati

InstitutionShahid beheshti university of medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 29 Covid-19 publications, with a maximum of 7 publications in November 2020
    All Publications
    Bar chart showing 71 publications over 10 distinct years, with a maximum of 18 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bahramnezhad F, Ghorbani B, Ghaedrahamt M, Jamaati H. Coronavirus-disease-2019-induced antiphospholipid-like syndrome: a case report. J Med Case Rep. 2021 Jul 29; 15(1):408. PMID: 34321077.
      Citations:    Fields:    Translation:Humans
    2. Fakharian A, Barati S, Mirenayat M, Rezaei M, Haseli S, Torkaman P, Yousefian S, Dastan A, Jamaati H, Dastan F. Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107961. PMID: 34426106.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    3. Mortaz E, Tabarsi P, Jamaati H, Dalil Roofchayee N, Dezfuli NK, Hashemian SM, Moniri A, Marjani M, Malekmohammad M, Mansouri D, Varahram M, Folkerts G, Adcock IM. Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727. PMID: 33968010.
      Citations: 2     Fields:    Translation:Humans
    4. Tolouian R, Mulla ZD, Jamaati H, Babamahmoodi A, Marjani M, Eskandari R, Dastan F. Effect of bromhexine in hospitalized patients with COVID-19. J Investig Med. 2021 Mar 15. PMID: 33722999.
      Citations: 1     Fields:    
    5. Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, Moniri A, Abtahian Z, Haseli S, Mortaz E, Dastan A, Mohamadnia A, Vahedi A, Monjazebi F, Yassari F, Fadaeizadeh L, Saffaei A, Dastan F. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947. PMID: 33607104.
      Citations: 12     Fields:    Translation:Humans
    6. Alipoor SD, Mortaz E, Jamaati H, Tabarsi P, Bayram H, Varahram M, Adcock IM. COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol. 2021; 11:563085. PMID: 33643932.
      Citations: 7     Fields:    Translation:Humans
    7. Monjazebi F, Dolabi SE, Tabarestani ND, Moradian G, Jamaati H, Peimani M. Journey of Nursing in COVID-19 Crisis: A Qualitative Study. J Patient Exp. 2021; 8:2374373521989917. PMID: 34179367.
      Citations:    
    8. Hashemian SR, Aliannejad R, Zarrabi M, Soleimani M, Vosough M, Hosseini SE, Hossieni H, Keshel SH, Naderpour Z, Hajizadeh-Saffar E, Shajareh E, Jamaati H, Soufi-Zomorrod M, Khavandgar N, Alemi H, Karimi A, Pak N, Rouzbahani NH, Nouri M, Sorouri M, Kashani L, Madani H, Aghdami N, Vasei M, Baharvand H. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther. 2021 01 29; 12(1):91. PMID: 33514427.
      Citations: 33     Fields:    Translation:HumansCellsCTClinical Trials
    9. Mortaz E, Bassir A, Dalil Roofchayee N, Dezfuli NK, Jamaati H, Tabarsi P, Moniri A, Rezaei M, Mehrian P, Varahram M, Marjani M, Mumby S, Adcock IM. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407. PMID: 33631512.
      Citations: 1     Fields:    Translation:Humans
    10. Mortaz E, Jamaati H, Varahram M, Dezfuli NK, Adocok IM. Programmed Cell Death Protein 1 (PD-1) Molecule in Coronavirus Disease 2019 (COVID-19)? Tanaffos. 2021 Jan; 20(1):1-2. PMID: 34394361.
      Citations:    
    11. Baghaei P, Dastan F, Marjani M, Moniri A, Abtahian Z, Ghadimi S, Valizadeh M, Heshmatnia J, Sadat Mirenayat M, Abedini A, Kiani A, Eslaminejad A, MohammadReza Hashemian S, Jamaati H, Zali A, Akbar Velayati A, Tabarsi P. Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329. PMID: 33412395.
      Citations: 9     Fields:    Translation:Humans
    12. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021 Nov-Dec; 27(6):486-492. PMID: 33358260.
      Citations: 7     Fields:    Translation:HumansCells
    13. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Mortaz E, Tabarsi P, Marjani M, Malekmohammad M, Dastan F, Mortazavi SM, Sadr M, Idani E, Khoundabi B, Mohamadnia A, Abedini A, Kiani A, Moniri A, Nadji SA, Yassari F, Mokhber Dezfuli M, Pourabdollah M, Varahram M, Eshaghi F, Malekpour M, Velayati A. Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299. PMID: 33959166.
      Citations: 1     
    14. Vahedi A, Tabasi F, Monjazebi F, Hashemian SMR, Tabarsi P, Farzanegan B, Malekmohammad M, Salimi A, Salimi M, Raoufy MR, Jamaati H, Velayati AA. Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study. Tanaffos. 2020 Dec; 19(4):300-311. PMID: 33959167.
      Citations: 2     
    15. Fadaizadeh L, Jamaati H, Varahram M, Taheri MJ, Sanaat M. Follow-Up of Coronavirus Infected Patients Using Telemedicine in a Referral Pulmonary Center. Tanaffos. 2020 Dec; 19(4):356-363. PMID: 33959173.
      Citations:    
    16. Tabarsi P, Barati S, Jamaati H, Haseli S, Marjani M, Moniri A, Abtahian Z, Dastan A, Yousefian S, Eskandari R, Saffaei A, Monjazebi F, Vahedi A, Dastan F. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205. PMID: 33214093.
      Citations: 18     Fields:    Translation:Humans
    17. Mortaz E, Malkmohammad M, Jamaati H, Naghan PA, Hashemian SMR, Tabarsi P, Varahram M, Zaheri H, Chousein EGU, Folkerts G, Adcock IM. Correction to: Silent hypoxia: higher NO in red blood cells of COVID-19 patients. BMC Pulm Med. 2020 Nov 10; 20(1):294. PMID: 33172417.
      Citations:    Fields:    
    18. Alipoor SD, Jamaati H, Tabarsi P, Mortaz E. Immunopathogenesis of Pneumonia in COVID-19. Tanaffos. 2020 Nov; 19(2):79-82. PMID: 33262791.
      Citations: 1     
    19. Citations: 2     
    20. Najafi A, Ghanei M, Janbabaei G, Velayati AA, Saadat SH, Jamaati H, Tabarsi P, Dastan F, Ram M, Darabi E, Fathi S, Gholami Fesharaki M, Ghazale AH, Saloo S. Real Clinical Practice and Therapeutic Management Following COVID-19 Crisis in two Hospitals in Iran: A Statistical and Conceptual View. Tanaffos. 2020 Nov; 19(2):112-121. PMID: 33262798.
      Citations:    
    21. Baghaei P, Nadji SA, Marjani M, Moniri A, Hashemian SM, Sheikhzade H, Abtahian Z, Heshmatnia J, Abedini A, Jamaati H, Mansourafshar B, Ahmadi ZH, Mokhber Dezfuli M, Seifi S, Sadeghi M, Mirenayat MS, Yassari F, Lookzadeh S, Farzanegan B, Kiani A, Vasheghani M, Dastan F, Eslaminejad A, Malekmohammad M, Varahram M, Zali A, Tabarsi P, Velayati AA. Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128. PMID: 33262799.
      Citations:    
    22. Malekmohammad M, Hashemian SMR, Mansourafshar B, Jamaati H. Neurological Manifestations of COVID-19: A Case Report. Tanaffos. 2020 Nov; 19(2):160-164. PMID: 33262805.
      Citations:    
    23. Mortaz E, Malkmohammad M, Jamaati H, Naghan PA, Hashemian SM, Tabarsi P, Varahram M, Zaheri H, Chousein EGU, Folkerts G, Adcock IM. Silent hypoxia: higher NO in red blood cells of COVID-19 patients. BMC Pulm Med. 2020 Oct 16; 20(1):269. PMID: 33066765.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    24. Pourabdollah Toutkaboni M, Askari E, Askari E, Khalili N, Tabarsi P, Jamaati H, Jamaati H, Velayati AA, Dorudinia A, Rezaei M, Nadji SA, Mohamadnia A, Khalili N. Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes New Infect. 2020 Nov; 38:100777. PMID: 33042553.
      Citations: 2     
    25. Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688. PMID: 32544867.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    26. Talaee N, Varahram M, Jamaati H, Salimi A, Attarchi M, Kazempour Dizaji M, Sadr M, Hassani S, Farzanegan B, Monjazebi F, Seyedmehdi SM. Stress and burnout in health care workers during COVID-19 pandemic: validation of a questionnaire. Z Gesundh Wiss. 2020 Jun 06; 1-6. PMID: 32837840.
      Citations: 19     
    27. Dastan F, Saffaei A, Mortazavi SM, Jamaati H, Adnani N, Samiee Roudi S, Kiani A, Abedini A, Hashemian SM. Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341. PMID: 32353526.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    28. Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A, Hashemian SM. A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol. Iran J Pharm Res. 2020; 19(1):31-36. PMID: 32922466.
      Citations: 15     
    29. Jamaati H, Dastan F, Esmaeili Dolabi S, Varahram M, Hashemian SM, Nasiri Rayeini S, Farzanegan B, Monjazebi F. COVID-19 in Iran: A model for Crisis Management and Current Experience. Iran J Pharm Res. 2020; 19(2):1-8. PMID: 33224206.
      Citations: 2     
    Jamaati's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (125)
    Explore
    _
    Co-Authors (155)
    Explore
    _
    Similar People (60)
    Explore
    _